Integrating breast cancer genomics and proteomics
15 May 2013
Integrating breast cancer genomics and proteomics
Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence
Implementation of individualised treatment and the WINTHER trial
Importance of personalised medicine and the WIN Consortium
The role of physicians and researchers in the medical community
Goal of the 2013 WIN Symposium
Japan Myeloma Network
Challenges to the development of personalised medicine
Developing technologies for personalised treatment
Development and expansion of the IFOM-IEO campus
New developments in molecular imaging
Translational and tailored, but can we afford it?